Completed Equality Screenings - Quarter 2 - July 2014 - September 2014
Date published:
In fulfilling the commitments within its Equality Scheme the Department equality screens policies to assess the impact and determine if a full Equality Impact Assessment (EQIA) is required.
Documents
- Development of Integrated Care Partnerships (ICPs)
- Minimum Care Standards for Children’s Homes
- Minimum Care Standards for Independent Healthcare Establishments
- NICE Clinical Guideline CG174 - Intravenous fluid therapy in adults in hospital
- NICE Clinical Guideline CG179 - Management and Prevention of Pressure Ulcers (Updates and replaces Pressure relieving devices (CG7) and Pressure ulcer management (CG29)
- NICE Clinical Guideline CG180 - The management of atrial fibrillation (updates & replaces CG36)
- NICE Clinical Guideline CG181 - Lipid Modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
- NICE Clinical Guideline CG182 - Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care
- NICE Technology Appraisal TA312 - Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
- NICE Technology Appraisal TA313 - Ustekinumab for treating active psoriatic arthritis
- NICE Technology Appraisal TA314 - Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120)
- NICE Technology Appraisal TA315 - Canagliflozin in combination therapy for treating type 2 diabetes
- NICE Technology Appraisal TA316 - Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen
- NICE Technology Appraisal TA317 - Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182)
- NICE Technology Appraisal TA318 - Lubiprostone for treating chronic idiopathic constipation
- NICE Technology Appraisal TA319 - Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma
- UK-wide regulations to introduce standardised (plain) packaging of tobacco products
- Health (Miscellaneous Provisions) Bill (Northern Ireland) 2014 – regulations to prohibit the sale of nicotine-containing products, including e-cigarettes, to persons under the age of eighteen
- Service Framework for Cardiovascular Health and Wellbeing
- Strengthening the Commitment: A Northern Ireland draft Action Plan for local implementation of the recommendations of the UK Modernising Learning Disabilities